Impact Of Alternative Pain Management Therapies On The Pain Management Devices Market Industry Trends Gaining Momentum in the Global Pain Management Devices And Therapies Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pain Management Devices And Therapies Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for pain management devices and therapies has seen a rapid expansion lately. It is projected to rise from $4.83 billion in 2024 to $5.34 billion in 2025, representing a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the previous growth include an increase in chronic pain instances, an escalating demand for less invasive pain management techniques, a rise in custom-tailored pain management demands, growth in the elderly population, and heightened awareness surrounding pain management alternatives.

Pain Management Devices And Therapies Market Size Forecast: What's the Projected Valuation by 2029?
There is expected to be significant growth in the market for pain management devices and therapies in the coming years, with a projected market size of $6.91 billion by 2029 growing at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth over the forecast period can be associated with the emergence of non-opioid alternatives, advancements in remote and digital healthcare, an increasing opioid crisis, recognition for holistic pain management and the emphasis on value-based care. The period is also predicted to see major trends such as progress in pain management technology, the advent of neuromodulation devices, the rise of digital therapeutics, wearable pain management devices and regenerative therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

What Are the Drivers Transforming the Pain Management Devices And Therapies Market?
The surge in the necessity for pain control tools, alongside a rising prevalence of chronic illnesses, is fueling the expansion of the pain control devices and therapies industry. Severe ailments such as cancer and heart strokes often result in intolerable pain for the patients, thereby provoking a need for pain relief medications and treatments. Such diseases linger over an extended duration and exacerbate the patient's health. For example, as stated in an article by the Brazilian Journal of Nephrology published in September 2024, about 60% of patients suffering from chronic kidney disease reported some degree of pain, necessitating pain alleviation drugs. Similarly, a study in the 'US National Library of Medicine' indicated that around 45% or 133 million out of all Americans had at least a single chronic illness. The report further indicated that over two-thirds of all fatalities resulted from one of the chronic ailments, including coronary heart disease, cancer, stroke, persistent obstructive pulmonary disease, and diabetes. This escalation in chronic illnesses is heightening the need for pain control devices and treatments, hence promoting the growth of the pain control devices and therapies market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2490&type=smp

What Long-Term Trends Will Define the Future of the Pain Management Devices And Therapies Market?
The growth of the pain management devices and therapies market is being hindered by the presence of alternative pain management solutions. Treatments such as acupuncture, marijuana therapy, dietary supplements, and vitamins are increasingly substituting costly pain management devices and equipment. These non-traditional therapies can potentially alleviate pains related to bad backs, osteoarthritis, and headaches. An example is acupuncture, which effectively addresses pain caused by multiple conditions including fibromyalgia, osteoarthritis, back and sports injuries. This ancient Chinese practice involves the placement of thin needles into specific body points and unlike conventional pain warfare devices, it is less expensive and doesn't exhibit significant side effects. This increasing adoption of alternative therapies is impacting the sales, thus curbing the growth of the pain management devices and therapies market.

Which Segments in the Pain Management Devices And Therapies Market Offer the Most Profit Potential?
The pain management devices and therapies market covered in this report is segmented -

1) By Type: Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps
2) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices
3) By Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS
4) By Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices
5) By Analgesic Infusion Pumps: Intrathecal Infusion Pumps, External Infusion Pumps
6) By Application: Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma

Subsegments:
1) By Electrical Stimulators: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Implantable Electrical Stimulators
2) By Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Neurostimulators: Spinal Cord Stimulators, Peripheral Nerve Stimulators
4) By Analgesic Pumps: Patient-Controlled Analgesia (PCA) Pumps, Intrathecal Analgesic Pumps

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2490&type=smp

Which Firms Dominate the Pain Management Devices And Therapies Market by Market Share and Revenue in 2025?
Major companies operating in the pain management devices and therapies market include Abbott Laboratories, AstraZeneca plc, Pfizer Inc., Boston Scientific Corporation, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Medtronic plc, Novartis AG, Baxter International Inc., Johnson & Johnson, Eli Lilly & Company, Endo Health Solutions Inc., Smiths Medical Inc., Becton Dickinson and Company, AbbVie Inc., Astellas Pharma Inc., Bayer AG, DJO Global Inc., B. Braun Melsungen AG, Neurotech Na, Nevro Corp, Sanofi SA, Purdue Pharma LP, Zogenix Inc., Bausch Health Companies Inc., NeuroMetrix Inc., Medovex Corporation, Halyard Health Inc., Flowonix Medical Inc., Pain Management Technologies Inc.

Which Regions Offer the Highest Growth Potential in the Pain Management Devices And Therapies Market?
The countries covered in the pain management devices and therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2490

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.